Jupiter Life Line Hospitals Limited Share Price & Analysis
Price Chart
Fundamentals
Strengths
- Low debt relative to equity (D/E 0.4x)
- Near 52-week low — potential value zone (₹230)
Concerns
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,758 | ₹4.2L Cr | 33.2 | 5.05 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹9,559 | ₹2.4L Cr | 79.8 | 15.15 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,557 | ₹1.7L Cr | 79.3 | 9.43 | 27.4 | 15.2 | 0.77 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,176 | ₹1.1L Cr | 23.1 | 4.37 | 21.2 | 21.1 | 0.38 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,137 | ₹1.1L Cr | 52.8 | 12.35 | 21.2 | 17.4 | 0.88 |
| CIPLA Cipla Limited | ₹1,366 | ₹1.1L Cr | 30.2 | 3.21 | 11.6 | 15.5 | 0.01 |
| LAURUSLABS Laurus Labs Limited | ₹2,182 | ₹1.1L Cr | 97.4 | 22.22 | 18.3 | 17.8 | 0.46 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
JLHL · as of Mar 2026
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 40.91% | 40.91% | 40.91% | 40.91% | 40.91% | 40.91% |
| FII | 3.96% | 4.17% | 6.06% | 8.84% | 10.04% | 10.04% |
| DII | 13.92% | 14.16% | 13.85% | 13.46% | 15.75% | 15.64% |
| Public | 41.19% | 40.76% | 39.18% | 36.79% | 33.31% | 33.43% |
Corporate Events
To consider and approve the financial results for the period ended September 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026
Face Value Split (Sub-Division) - From Rs 10/- Per Share To Rs 2/- Per Share
Interim Dividend - Re 1 Per Share
To consider and approve the financial results for the period ended March 31, 2026
Dividend - Re 1 Per Share
Dividend - Re 1 Per Share
Latest News
All newsJupiter Life Line hosts investor call with updates.
*Jupiter Life Line hosts investor call with updates.* The company shared recent operational and strategic insights during its analyst and institutional investor meet. A recording of the session is available on the NSE portal. No major financial announcements or guidance revisions were disclosed. 📊 *STOCKS:* $JUPITERHOSP | 🏢 *SECTOR:* Corporate | #LOWIMPACT #InvestorCall
Jupiter Life Line Hospitals shares no major updates ahead of AGM
*Jupiter Life Line Hospitals shares no major updates ahead of AGM* The company shared the weblink for its AGM notice and annual report. No financial or operational updates were disclosed. Key stakeholders await further details during the upcoming meeting. 📊 *STOCKS:* JUPITER | 🏢 *SECTOR:* Healthcare | #LOWIMPACT #AGM
Jupiter Life Line publishes statutory newspaper notice
*Jupiter Life Line publishes statutory newspaper notice* The company has released a copy of its newspaper publication as part of regulatory compliance. Such filings are routine and do not indicate operational or financial changes. No immediate market-moving information is disclosed. 📊 *STOCKS:* JTLH | 🏢 *SECTOR:* Healthcare | #LOWIMPACT #CorporateFiling
Jupiter Life Line to hold 24th AGM
*Jupiter Life Line to hold 24th AGM* for FY 2025-26. The notice confirms the annual general meeting of shareholders. No major announcements expected beyond routine disclosures. AGMs typically cover dividend proposals and management updates. 📊 *STOCKS:* JUPITER | 🏢 *SECTOR:* Healthcare | #LOWIMPACT #AGM
Jupiter Life Line to hold AGM via video conference
*Jupiter Life Line to hold AGM via video conference*. Jupiter Life Line Hospitals Limited has announced the 24th Annual General Meeting on **July 17, 2026**, to be conducted via video conference. The notice was filed as part of regulatory compliance. No financial or strategic updates were disclosed. 📊 *STOCKS:* JUPITERHOSP | 🏢 *SECTOR:* Healthcare | #LOWIMPACT #AGM
Financials
Quarterly Results
| Metric | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹365 Cr 7.4% | ₹394 Cr 11.6% | ₹353 Cr 4.7% | ₹337 Cr 1.2% | ₹333 Cr 0.6% | ₹335 Cr 15.9% | ₹289 Cr 0.7% | ₹291 Cr |
| Op. Profit | ₹83 Cr 9.8% | ₹92 Cr 17.9% | ₹78 Cr 2.5% | ₹80 Cr 5.3% | ₹76 Cr 2.6% | ₹78 Cr 20.0% | ₹65 Cr 3.2% | ₹63 Cr |
| OPM | 23.0% 0.0% | 23.0% 4.5% | 22.0% 8.3% | 24.0% 4.3% | 23.0% 0.0% | 23.0% 0.0% | 23.0% 4.5% | 22.0% |
| Net Profit | ₹42 Cr 26.3% | ₹57 Cr 29.5% | ₹44 Cr 2.2% | ₹45 Cr 13.5% | ₹52 Cr 0.0% | ₹52 Cr 15.6% | ₹45 Cr 0.0% | ₹45 Cr |
| EPS (₹) | 1.3 25.7% | 1.75 30.6% | 1.34 2.9% | 1.38 13.2% | 1.59 0.6% | 1.58 16.2% | 1.36 80.2% | 6.87 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | ₹1.5K Cr 15.2% | ₹1.3K Cr 21.3% | ₹1.1K Cr 20.2% | ₹893 Cr 21.8% | ₹733 Cr 50.8% | ₹486 Cr 5.0% | ₹463 Cr |
| Expenses | ₹1.2K Cr 15.7% | ₹999 Cr 20.2% | ₹831 Cr 20.3% | ₹691 Cr 19.1% | ₹580 Cr 38.4% | ₹419 Cr 10.6% | ₹379 Cr |
| Op. Profit | ₹343 Cr 13.2% | ₹303 Cr 25.2% | ₹242 Cr 20.4% | ₹201 Cr 31.4% | ₹153 Cr 128.4% | ₹67 Cr 20.2% | ₹84 Cr |
| OPM | 23.0% 0.0% | 23.0% 0.0% | 23.0% 0.0% | 23.0% 9.5% | 21.0% 50.0% | 14.0% 22.2% | 18.0% |
| Other Income | ₹37 Cr 48.0% | ₹25 Cr 13.6% | ₹22 Cr 175.0% | ₹8 Cr 100.0% | ₹4 Cr 0.0% | ₹4 Cr | ₹0 Cr |
| Interest | ₹33 Cr 200.0% | ₹11 Cr 57.7% | ₹26 Cr 38.1% | ₹42 Cr 4.5% | ₹44 Cr 12.8% | ₹39 Cr 50.0% | ₹26 Cr |
| Depreciation | ₹88 Cr 54.4% | ₹57 Cr 35.7% | ₹42 Cr 7.7% | ₹39 Cr 8.3% | ₹36 Cr 16.1% | ₹31 Cr 19.2% | ₹26 Cr |
| PBT | ₹260 Cr 0.4% | ₹261 Cr 33.8% | ₹195 Cr 51.2% | ₹129 Cr 67.5% | ₹77 Cr 3750.0% | ₹2 Cr 93.9% | ₹33 Cr |
| Tax % | 25.0% 3.8% | 26.0% 160.0% | 10.0% 76.7% | 43.0% 26.5% | 34.0% 86.3% | 248.0% 2380.0% | 10.0% |
| Net Profit | ₹194 Cr 0.0% | ₹194 Cr 9.6% | ₹177 Cr 142.5% | ₹73 Cr 43.1% | ₹51 Cr 2650.0% | ₹-2 Cr 106.7% | ₹30 Cr |
| EPS (₹) | 5.92 0.5% | 5.89 9.3% | 5.39 108.9% | 2.58 28.4% | 2.01 2333.3% | -0.09 107.7% | 1.17 |
| Div Payout | 3.0% 0.0% | 3.0% 25.0% | 4.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Sep 2026 | Mar 2026 | Sep 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|---|---|
Liabilities | |||||||||
| Equity Capital | ₹66 Cr 0.0% | ₹66 Cr 0.0% | ₹66 Cr 0.0% | ₹66 Cr 0.0% | ₹66 Cr 15.8% | ₹57 Cr 11.8% | ₹51 Cr 0.0% | ₹51 Cr 0.0% | ₹51 Cr |
| Reserves | ₹1.6K Cr 5.8% | ₹1.5K Cr 6.8% | ₹1.4K Cr 7.3% | ₹1.3K Cr 17.0% | ₹1.1K Cr 257.0% | ₹309 Cr 27.2% | ₹243 Cr 29.3% | ₹188 Cr 1.1% | ₹186 Cr |
| Borrowings | ₹669 Cr 14.6% | ₹584 Cr 44.9% | ₹403 Cr 2.5% | ₹393 Cr | ₹0 Cr 100.0% | ₹469 Cr 5.3% | ₹495 Cr 16.2% | ₹426 Cr 56.6% | ₹272 Cr |
| Other Liabilities | ₹261 Cr 11.1% | ₹235 Cr 39.9% | ₹168 Cr 0.0% | ₹168 Cr 50.0% | ₹112 Cr 25.8% | ₹151 Cr 25.8% | ₹120 Cr 3.2% | ₹124 Cr 31.9% | ₹94 Cr |
| Total Liabilities | ₹2.6K Cr 8.3% | ₹2.4K Cr 16.8% | ₹2.0K Cr 5.5% | ₹1.9K Cr 49.6% | ₹1.3K Cr 29.9% | ₹986 Cr 8.5% | ₹909 Cr 15.2% | ₹789 Cr 30.8% | ₹603 Cr |
Assets | |||||||||
| Fixed Assets | ₹1.4K Cr 4.0% | ₹1.4K Cr 38.7% | ₹998 Cr 2.0% | ₹978 Cr 36.2% | ₹718 Cr 0.3% | ₹720 Cr 5.3% | ₹684 Cr 8.6% | ₹630 Cr 44.8% | ₹435 Cr |
| CWIP | ₹194 Cr 50.4% | ₹129 Cr 56.4% | ₹296 Cr 60.0% | ₹185 Cr 150.0% | ₹74 Cr 155.2% | ₹29 Cr 7.4% | ₹27 Cr 3.8% | ₹26 Cr 160.0% | ₹10 Cr |
| Investments | ₹385 Cr 20.8% | ₹486 Cr 7.6% | ₹526 Cr 3.7% | ₹507 Cr 2882.4% | ₹17 Cr 750.0% | ₹2 Cr 33.3% | ₹3 Cr 57.1% | ₹7 Cr 250.0% | ₹2 Cr |
| Other Assets | ₹543 Cr 49.2% | ₹364 Cr 79.3% | ₹203 Cr 17.8% | ₹247 Cr 47.8% | ₹473 Cr 101.3% | ₹235 Cr 20.5% | ₹195 Cr 54.8% | ₹126 Cr 19.2% | ₹156 Cr |
| Total Assets | ₹2.6K Cr 8.3% | ₹2.4K Cr 16.8% | ₹2.0K Cr 5.5% | ₹1.9K Cr 49.6% | ₹1.3K Cr 29.9% | ₹986 Cr 8.5% | ₹909 Cr 15.2% | ₹789 Cr 30.8% | ₹603 Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|
| Operating CF | ₹268 Cr 0.4% | ₹267 Cr 132.2% | ₹115 Cr 34.7% | ₹176 Cr 28.5% | ₹137 Cr 11.4% | ₹123 Cr 66.2% | ₹74 Cr |
| Investing CF | ₹-442 Cr 11.1% | ₹-497 Cr 102.0% | ₹-246 Cr 161.7% | ₹-94 Cr 11.9% | ₹-84 Cr 71.5% | ₹-295 Cr 586.0% | ₹-43 Cr |
| Financing CF | ₹136 Cr 54.2% | ₹297 Cr 132.0% | ₹128 Cr 351.0% | ₹-51 Cr 259.4% | ₹32 Cr 82.6% | ₹184 Cr 675.0% | ₹-32 Cr |
| Net Cash Flow | ₹-38 Cr 157.6% | ₹66 Cr 2300.0% | ₹-3 Cr 109.7% | ₹31 Cr 63.5% | ₹85 Cr 608.3% | ₹12 Cr 1300.0% | ₹-1 Cr |
| Free Cash Flow | ₹-234 Cr 290.0% | ₹-60 Cr 306.9% | ₹29 Cr 71.0% | ₹100 Cr 117.4% | ₹46 Cr 139.0% | ₹-118 Cr 356.5% | ₹46 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 18d 50.0% | 12d 36.8% | 19d 0.0% | 19d 35.7% | 14d 12.5% | 16d 54.3% | 35d |
| Inventory Days | 49d 28.9% | 38d 7.3% | 41d 6.8% | 44d 12.8% | 39d 18.8% | 48d 25.0% | 64d |
| Days Payable | 121d 22.2% | 99d 17.5% | 120d 26.8% | 164d 4.5% | 157d 27.6% | 217d 19.0% | 268d |
| Cash Conv. Cycle | -54d 10.2% | -49d 16.9% | -59d 41.6% | -101d 2.9% | -104d 31.6% | -152d 10.1% | -169d |
| Working Capital Days | -21d 10.5% | -19d 280.0% | -5d 79.2% | -24d 0.0% | -24d 242.9% | -7d 141.2% | 17d |
| ROCE | 15.0% 16.7% | 18.0% 18.2% | 22.0% 4.8% | 21.0% 23.5% | 17.0% 142.9% | 7.0% | — |
Source: Screener.in · Lower days = better efficiency
About Jupiter Life Line Hospitals Limited
Incorporated in 2007, Jupiter Life Line Hospitals Limited is a multi-specialty tertiary and quaternary healthcare provider in the Mumbai Metropolitan Area (MMR) and western region of India.[1]
HealthcareHealthcare Services